Drug Research
Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France
Novo Nordisk announced the investment of more than 16 billion Danish kroner (2.1 billion euros) starting in 20231 to expand the existing production site in Chartres, France, for the current and future product portfolio within serious chronic diseases.
The investment...
Drug Research
BMS, Avidity add another $100M to cardiovascular partnership
Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), today announced a global licensing and research collaboration with Bristol Myers Squibb focused on the discovery, development and commercialization...
Drug Research
Almac, Queens University Launch Drug Discovery Facility in Belfast
Almac Discovery and Queen’s University Belfast reported a five-year project to develop a new Chemoproteomics Centre of Excellence for drug discovery. The multi-million-pound facility, which is jointly funded by Almac Discovery and a BBSRC Prosperity Partnership award, is a...
Drug Research
Berry Global Underlines Its Commitment to South East Asia Region
Berry Global will demonstrate its commitment to delivering innovative, patient-centric packaging, dispensing solutions, and drug delivery devices for India and the South Asia region on the company’s stand at this year’s CPHI India exhibition.
Berry will showcase a wide range...
Drug Research
Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics
Myricx Bio, a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads based on N-Myristoyltransferase inhibition (NMTi), and WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development...
Drug Research
Connected Devices Making Their Presence Felt In Pharma
The market when it comes to connected drug delivery devices is going through rapid growth, with an expected annual market growth rate of more than 20% between 2023 and 2030. This progress is driven, in part, by the increasing...
Drug Research
Reference Approval Agencies Expanded By NPRA In Malaysia
The National Pharmaceutical Regulatory Agency- NPRA of Malaysia has recently gone on to revise its guidelines with regards to the approval pathways for medicines that have already been authorized in certain overseas territories. The changes made by NPRA go on...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read